KMG Chemicals, Inc. (NASDAQ: KMGB), a global provider of
specialty chemicals in carefully focused markets, today
announced financial results for the first quarter ended
October 31, 2009.
Overview of First Quarter Results
For the first quarter ended October 31, 2009, net sales were
$49.4 million producing operating income of $8.0 million,
and record net income for a first quarter period of $4.6
million or $0.41 per diluted share. In the first fiscal
quarter of 2009, net sales were $52.2 million resulting in
operating income of $3.5 million, and net income of $1.6
million or $0.14 per diluted share.
In the fiscal 2010 first quarter, Wood Preservatives
generated $25.5 million or 52% of net sales, Electronic
Chemicals generated net sales of $23.0 million or 47% of the
total, while Animal Health generated net sales of $933,000,
or 1% of the total. In the first quarter of fiscal 2009,
Wood Preservatives generated net sales of $24.6 million or
47% of total net sales, Electronic Chemicals generated $26.2
million or 50% of sales, and Animal Health generated $1.4
million or 3% of sales.
Neal Butler, President and CEO of KMG, commented, “Fiscal
2010 started on a strong note and as we previously
announced, produced first quarter net income and earnings
per share of more than two and a half times last year’s
first quarter and also set a new record for the Company’s
first quarter period. For the past three years, our first
quarter diluted earnings per share have been flat at $0.14.
“Electronic Chemicals sales have been steadily improving
and finished the quarter close to their pre-recessionary
levels. Some of the increase in volume, relative to the past
three quarters, may be seasonal. Of special note, our
international unit achieved sales that approximated last
year’s first quarter and was once again profitable with
$148,000 of operating income for the quarter, a $180,000
improvement over last year. Our North American unit
generated operating profits of $1.3 million, down $228,000
from last year. Despite these positive indicators, we remain
cautious and believe challenging market conditions could
continue during fiscal 2010.
“Wood Treating Chemicals performed well in the first
quarter, and the year-over-year improvement was driven by a
favorable product mix, lower raw material costs, reduction
in amortization expense and improved pricing. As noted, Wood
Treating sales were $25.5 million compared to $24.6 million
in the same period in fiscal 2009. First quarter operating
income for Wood Treating was $9.2 million versus $4.0
million in fiscal 2009. Penta sales volumes declined about
9% from the 2009 average as utilities trimmed their
maintenance spending. As we indicated last month, we have
seen an increase in chlorine prices, which is an important
raw material for Penta production. While we have seen a
significant improvement in Penta operating margins in the
first quarter over last year due to lower amortization
expense and raw material costs, increases in the cost of
chlorine could negatively impact Penta operating margins in
the second quarter of fiscal 2010 to levels approaching the
2009 second quarter. First quarter Creosote revenues
increased as a result of a higher average sales price,
driven by a shift in our product mix resulting from a
temporary shortage of domestically produced Creosote, as
well as pricing action taken in response to our increased
cost for Creosote. First quarter Creosote sales volumes were
flat compared to average 2009 volumes, although volumes were
lower compared to the year earlier quarter. In the first
quarter of last fiscal year, Creosote margins were notably
reduced as a result of significant product cost increases.
Operating margins in this first quarter benefited from an
earlier pricing action taken in response to those cost
increases, as well as the temporary shift in product mix
discussed above. For the year as a whole, we anticipate a
partial retraction in profitability with increasing average
costs and an easing in demand for treated wood by utilities
and railroads, which will cause Wood Treating revenues to be
marginally less to flat in fiscal 2010 compared to fiscal
2009.”
Mr. Butler went on to say, “Animal Health sales in the
first quarter were down as our farm and livestock customers
continue to contend with high input costs and low beef and
poultry prices. This segment is seasonally weighted to our
fiscal third and fourth quarters. In the current year’s
first quarter, we entered into an agreement with AgriLabs,
an animal health sales-and-marketing company, to enhance
distribution and service to our customers as well as
generate greater exposure for our products in the cattle,
swine, dairy and equine markets. We continue to pursue
product line expansions as well as acquisition targets.”
Balance Sheet Discussion
John V. Sobchak, CFO of KMG, commented, “Net working capital
for the first quarter was $34.1 million, compared to $29.7
million at our fiscal year ended July 31st, due
to the increase in our cash position. Cash on October 31st
was $12.0 million compared to $7.2 million on July 31st.
In addition to this strong cash position, our $35 million
revolving credit facility is fully available. At the end of
the quarter, total borrowings had been reduced to $44.9
million due to the normal amortization of our term loan.
With $76.5 million of shareholders’ equity, we finished the
quarter with a debt to equity ratio below 0.6.”
Outlook
Mr. Butler concluded, “The measures we implemented in fiscal
2009 to improve supply chain and manufacturing efficiencies
are having the desired effect on our profitability thus far
in fiscal 2010. The exceptional first quarter results
provide a good start for earnings per share in fiscal 2010
to exceed last year’s record earnings. With our reduced debt
structure, a $35 million revolving credit facility that
remains untapped and a strong cash position, we are
well-positioned to finance and integrate our next
acquisition, which we look forward to completing in the
current fiscal year.”
Conference Call
Messrs. Butler and Sobchak will conduct a conference call
focusing on the financial results at 10:00 a.m. E.T. on
Monday, December 7, 2009. Interested parties may participate
in the call by dialing 866-861-6730. Please call in 10
minutes before the call is scheduled to begin, and ask for
the KMGB call (conference ID # 37820395).
The conference call will also be webcast live via the
Investor Relations section of KMG’s website at
www.kmgchemicals.com. To listen to the live call please
go to the website at least 15 minutes early to register,
download and install any necessary audio software. If you
are unable to listen live, the conference call will be
archived on the website.
About
KMG
KMG
Chemicals, Inc., through its subsidiaries, produces and distributes
specialty chemicals to carefully focused markets.
The Company grows by
acquiring and optimizing stable chemical product lines and
businesses with established production processes. Its current operations are
focused on the wood treatment, electronic, and agricultural chemical
markets.
For more
information, visit the Company's web site at www.kmgchemicals.com.
The information in this
news release includes certain forward-looking statements that are
based upon assumptions that in the future may prove not to have been
accurate and are subject to significant risks and uncertainties,
including statements as to the future performance of the company.
Although the company believes that the expectations reflected in its
forward-looking statements are reasonable, it can give no assurance
that such expectations or any of its forward-looking statements will
prove to be correct. Factors that could cause results to differ
include, but are not limited to, successful performance of internal
plans, product development acceptance, the impact of competitive
services and pricing and general economic risks and
uncertainties.
Contacts
KMG Chemicals, Inc.
John V. Sobchak, 713-600-3814
Chief Financial Officer
JSobchak@kmgchemicals.com
www.kmgchemicals.com
or
Investor Relations Counsel:
The Equity Group Inc.
Melissa Dixon, 212-836-9613
MDixon@equityny.com
or
Linda Latman, 212-836-9609
LLatman@equityny.com
www.theequitygroup.com
|
KMG Chemicals,
Inc.
Consolidated
Statements of Income
(In thousands,
except per share data)
(UNAUDITED)
|
| |
|
|
| |
|
Three Months Ended
|
| |
|
October 31,
|
| |
|
2009
|
|
2008
|
| |
|
|
|
|
| NET SALES |
|
$ |
49,414 |
|
|
$52,233 |
|
| |
|
|
|
|
| COST OF SALES |
|
|
31,023 |
|
|
36,703 |
|
| |
|
|
|
|
| Gross Profit |
|
|
18,391 |
|
|
15,530 |
|
| |
|
|
|
|
| SELLING, GENERAL AND
ADMINISTRATIVE EXPENSES |
|
|
10,441 |
|
|
12,005 |
|
| |
|
|
|
|
| Operating income |
|
|
7,950 |
|
|
3,525 |
|
| |
|
|
|
|
| OTHER INCOME (EXPENSE):
|
|
|
|
|
| Interest income |
|
|
1 |
|
|
2 |
|
| Interest expense |
|
|
(557 |
) |
|
(879 |
)
|
| Other, net |
|
|
(28 |
) |
|
(33 |
)
|
| |
|
|
|
|
| Total other expense, net
|
|
|
(584 |
) |
|
(910 |
)
|
| |
|
|
|
|
| INCOME BEFORE INCOME TAXES
|
|
|
7,366 |
|
|
2,615 |
|
| |
|
|
|
|
| Provision for income taxes
|
|
|
(2,746 |
) |
|
(999 |
)
|
| |
|
|
|
|
| NET INCOME |
|
$ |
4,620 |
|
|
$1,616 |
|
| |
|
|
|
|
| EARNINGS PER SHARE: |
|
|
|
|
| Basic |
|
$ |
0.41 |
|
|
$ |
0.15 |
|
| Diluted |
|
$ |
0.41 |
|
|
$ |
0.14 |
|
| |
|
|
|
|
| WEIGHTED AVERAGE SHARES
OUTSTANDING: |
|
|
|
|
| Basic |
|
|
11,144 |
|
|
11,068 |
|
| Diluted |
|
|
11,375 |
|
|
11,223 |
|
| |
|
|
|
|
| |
|
|
|
|
| SUPPLEMENTAL DATA: |
|
|
|
|
| Depreciation and amortization
expense |
|
$ |
1,379 |
|
|
$ 1,778 |
|
|
KMG Chemicals,
Inc.
Balance Sheet
Highlights
(In thousands)
(UNAUDITED)
|
| |
|
|
|
| |
October 31,
|
|
July 31,
|
| |
2009
|
|
2009
|
| |
|
|
|
| |
|
|
|
| Cash and cash equivalents
|
$ |
11,994 |
|
$ |
7,174 |
| |
|
|
|
| Net working capital |
|
34,055 |
|
|
29,724 |
| |
|
|
|
| Total assets |
|
149,507 |
|
|
143,508 |
| |
|
|
|
| Long-term debt, including current
portion |
|
44,916 |
|
|
46,292 |
| |
|
|
|
| Shareholders’ Equity |
|
76,525 |
|
|
70,977 |